A previous study indicated that the TGF-β signaling pathway is implicated in malignant phenotypes in human EC[44], and activation of the TGF-β/Smad2/3 signaling pathway could enhance endometrial cancer stemness[45]. This evidence concerns the gene SMAD2 and endometrial cancer.